Liver Cirrhosis

Displaying 1 - 9 of 9CSV
Prasad, K., Bhattacharya, D., Shams, S. G. E., Izarraras, K., Hart, T., Mayfield, B., Blaszczyk, M. B., Zhou, Z., Pajvani, U. B., Friedman, S. L., & Bhattacharya, M. (2024). Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells. Cells, 13(19), 1651. https://doi.org/10.3390/cells13191651
Publication Date
Stoffel, E., Hwang, S. Y., Qian, X., Geller, B., Morelli, G., & Zhang, W. (2024). Sarcopenia is an independent risk factor for short-term mortality in patients undergoing transjugular intrahepatic portosystemic shunt. European Journal of Gastroenterology & Hepatology, 36(8), 1010–1015. https://doi.org/10.1097/meg.0000000000002790
Publication Date
Steffani, M., Geng, Y., Pajvani, U. B., & Schwabe, R. F. (2024). Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis. Journal of Clinical Investigation, 134(7). https://doi.org/10.1172/jci179710
Publication Date
Li, M., Itzel, T., Montagut, N. E., Falconer, T., Daza, J., Park, J., Cheong, J. Y., Park, R. W., Wiest, I., Ebert, M. P., Hripcsak, G., & Teufel, A. (2023). Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis. Scandinavian Journal of Gastroenterology, 58(12), 1505–1513. https://doi.org/10.1080/00365521.2023.2239974
Publication Date
Patel, A., Bowman, C. A., Prause, N., Kilaru, S. M., Nguyen, A., Kogekar, N., Cohen, C., Channen, L., Harty, A., Perumalswami, P., Dietrich, D., Schiano, T., Woodrell, C., & Agarwal, R. (2023). Outcomes of a 3-Year Quality Improvement Study to Improve Advance Care Planning in Patients With Decompensated Cirrhosis. American Journal of Gastroenterology, 119(3), 580–583. https://doi.org/10.14309/ajg.0000000000002570
Publication Date
Hagström, H., Thiele, M., Sharma, R., Simon, T. G., Roelstraete, B., Söderling, J., Sundström, J., & Ludvigsson, J. F. (2023). Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease. Clinical Gastroenterology and Hepatology, 21(7), 1841-1853.e12. https://doi.org/10.1016/j.cgh.2022.10.022
Publication Date
Hagström, H., Simon, T. G., Söderling, J., & Ludvigsson, J. F. (2023). Autopsy histology data suggest cirrhosis is frequently under-reported on death certificates. Hepatology Communications, 7(2), e0015–e0015. https://doi.org/10.1097/hc9.0000000000000015
Publication Date
Ufere, N. N., Patzer, R. E., Kavalieratos, D., Louissaint, J., Kaplan, A., & Cross, S. H. (2022). Rural-Urban Disparities in Mortality From Cirrhosis in the United States From 1999 to 2019. American Journal of Gastroenterology, 117(7), 1162–1165. https://doi.org/10.14309/ajg.0000000000001712
Publication Date
Hagström, H., Thiele, M., Simon, T. G., Sharma, R., Röckert Tjernberg, A., Roelstraete, B., Söderling, J., & Ludvigsson, J. F. (2022). Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease. United European Gastroenterology Journal, 10(2), 198–211. Portico. https://doi.org/10.1002/ueg2.12200
Publication Date